Noninvasive brain stimulation, considered selectively within a fully private, multidisciplinary residential treatment plan.
Transcranial magnetic stimulation, commonly known as TMS, is a noninvasive form of brain stimulation used in psychiatry and investigated across a growing range of neurological and psychological conditions.
TMS uses controlled magnetic pulses delivered through a coil positioned against the scalp. These pulses induce small electrical currents in targeted areas of the brain and can influence the activity of neural networks involved in mood, behavior, cognition, and other functions.
At THE BALANCE, TMS is not treated as a technological shortcut or a stand-alone solution. It may be considered when assessment identifies a clinically appropriate indication and when the expected benefit, evidence, alternatives, risks, provider qualifications, and treatment logistics are sufficiently clear.
Each fully private residential program is dedicated to one client. When TMS forms part of the plan, sessions can therefore be coordinated with psychiatric care, psychotherapy, medical treatment, sleep, nutrition, movement, and the other elements required by the individual.
What Is Transcranial Magnetic Stimulation?
Transcranial magnetic stimulation is a form of noninvasive neuromodulation. A treatment coil generates rapidly changing magnetic fields that pass through the scalp and skull and induce electrical activity in underlying brain tissue.
The clinician selects the stimulation location, intensity, frequency, pattern, and number of pulses according to the protocol being used. Repeated sessions are known as repetitive transcranial magnetic stimulation, or rTMS.
Different TMS systems do not necessarily stimulate the same regions or use the same protocols. Conventional rTMS, deep TMS, and theta burst stimulation should therefore not be treated as interchangeable simply because they all use magnetic stimulation.
How Does TMS Therapy Work?
TMS is intended to influence the activity of neural circuits associated with the condition being treated. Depending on the protocol, stimulation may increase or decrease cortical excitability and alter activity within connected neural networks.
In depression treatment, for example, commonly used protocols target areas of the prefrontal cortex involved in mood regulation. Other protocols use different stimulation sites and patterns depending on the indication.
The biological effects of TMS are more complex than simply switching an area of the brain “on” or “off.” Treatment response depends on the individual, diagnosis, stimulation parameters, brain network involved, concurrent treatments, and other factors.
What Happens During a TMS Session?
Before treatment begins, a qualified professional reviews the indication, medical and psychiatric history, medication, neurological history, implanted devices, seizure risk, and other relevant factors.
During a typical session:
- The client is positioned comfortably. Treatment is generally delivered while the person is awake.
- The coil is positioned. A magnetic coil or specialized treatment helmet is placed against the scalp according to the selected protocol.
- Stimulation is delivered. The client hears clicking sounds and may feel tapping, pressure, or movement of facial or scalp muscles.
- The client is monitored. Comfort, tolerance, symptoms, and any adverse effects are assessed.
- The response is reviewed over time. Treatment is continued, adjusted, paused, or stopped according to the clinical response and protocol.
Session duration varies considerably. Some conventional protocols take approximately 20 to 40 minutes, while certain theta burst or accelerated protocols can be substantially shorter. There is no single correct treatment duration for every device or indication.
TMS for Depression
Major depressive disorder is the psychiatric condition for which TMS has the most established clinical role. Specific TMS systems have been cleared in the United States for defined populations with depressive episodes, including people who have not achieved satisfactory improvement with previous antidepressant treatment.
TMS may be considered when depression has not responded adequately to medication or psychotherapy, when medication has produced difficult adverse effects, or when a psychiatrist determines that neuromodulation may reasonably complement the wider treatment plan.
It should not be assumed that treatment-resistant depression has one neurological cause that TMS can simply correct. Depression may involve psychiatric, medical, psychological, developmental, sleep-related, hormonal, relational, and environmental factors.
At THE BALANCE, TMS for depression would therefore sit within a broader depression treatment strategy rather than replace diagnostic clarification, psychotherapy, psychiatric review, medication management, or attention to contributing medical factors.
TMS for Obsessive-Compulsive Disorder
Specific deep TMS systems have received U.S. regulatory clearance as an adjunctive treatment for adults with obsessive-compulsive disorder.
This is important because OCD can remain significantly impairing even after appropriate psychotherapy and medication. TMS may be considered for selected clients when a psychiatrist determines that the indication, treatment history, protocol, and expected benefit support its use.
TMS should not displace established OCD treatment. Exposure and response prevention and appropriate pharmacological treatment remain central components of care for many people with OCD.
The question is therefore not whether TMS is “better” than psychotherapy or medication, but whether it has a useful role within the treatment sequence for this particular person.
TMS and Anxiety
TMS and anxiety require careful wording because “anxiety” covers several different clinical conditions.
Specific deep TMS systems have received U.S. clearance for reducing comorbid anxiety symptoms in adults being treated for major depressive disorder. This is often described as treatment of anxious depression.
That is different from a blanket regulatory clearance for generalized anxiety disorder, panic disorder, phobias, or all anxiety disorders.
Research has investigated TMS in several anxiety-related conditions, but results, protocols, and evidence quality vary. A diagnosis of anxiety by itself is therefore not sufficient reason to recommend TMS.
TMS for PTSD and Trauma-Related Symptoms
TMS has been studied as a potential intervention for post-traumatic stress disorder, including through stimulation of prefrontal brain networks associated with emotional regulation and threat processing.
However, the evidence remains mixed. Trials use different stimulation targets, frequencies, treatment schedules, populations, and combinations with psychotherapy. Some studies report symptom improvement, while systematic reviews have highlighted substantial heterogeneity and uncertainty.
TMS should therefore not be presented as an established cure for PTSD or as a way to restore a traumatized brain to a presumed “normal” state.
Where it is considered, the decision should sit within a comprehensive trauma and PTSD treatment plan that considers stabilization, psychotherapy, psychiatric comorbidity, sleep, dissociation, physical health, relationships, and the client’s capacity to engage safely in treatment.
TMS and Smoking Cessation
Specific deep TMS systems have received U.S. clearance as an aid in short-term smoking cessation for adults.
This does not mean that TMS removes nicotine dependence by itself. Smoking involves learned behavior, nicotine dependence, reward, environmental triggers, routines, stress responses, and social factors.
Where TMS is used, it should form part of a wider smoking-cessation strategy that may include behavioral treatment, medical assessment, medication or nicotine-replacement approaches when appropriate, and planning for relapse risk.
TMS and Other Addictions
TMS is also being investigated for substance-use disorders and behavioral addictions because neural systems involved in reward, motivation, craving, impulse control, and decision-making are relevant to addiction.
Research interest should not be confused with established efficacy for all addictions. A TMS device cleared to aid smoking cessation cannot automatically be assumed to treat alcohol, cocaine, cannabis, opioids, gambling, or other addictive behaviors.
At THE BALANCE, any neurobiological intervention for addiction must remain part of a wider addiction treatment plan addressing withdrawal risk, psychiatric conditions, trauma, behavior, relationships, environment, relapse prevention, and continuing care.
TMS for Chronic Pain
Repetitive TMS has been studied for several forms of chronic and neuropathic pain. Research suggests that stimulation of selected motor and cortical networks may influence pain processing in some populations.
However, chronic pain is not one uniform condition, and the optimal stimulation site, protocol, treatment duration, and expected durability vary. Regulatory status also differs by country, device, and indication.
THE BALANCE would not present TMS as a universal pain treatment. A person with chronic pain may require medical, neurological, musculoskeletal, psychiatric, sleep, medication, and functional assessment before neuromodulation is considered.
TMS for Neurological Conditions
TMS is being investigated or used in specialized settings across a range of neurological presentations, including migraine, movement disorders, post-stroke rehabilitation, and other conditions.
These uses involve different technologies, regulatory pathways, protocols, and levels of evidence. A general statement that “TMS treats neurological disorders” would therefore be misleading.
Where neurological symptoms are relevant, THE BALANCE may coordinate appropriate neurological assessment or an independent specialist pathway before determining whether TMS has a legitimate role.
TMS and Psychosis
Research has explored TMS for selected symptoms associated with schizophrenia and other psychotic disorders, including auditory hallucinations and negative symptoms.
This remains a specialist area. TMS should not be presented as an established treatment that places psychosis into remission, and it does not replace antipsychotic treatment, psychiatric monitoring, risk assessment, or other established interventions.
A person experiencing psychosis requires psychiatric assessment before any neuromodulation treatment is considered.
TMS Compared With ECT
TMS and electroconvulsive therapy are different treatments and should not be positioned as simple substitutes for one another.
TMS is noninvasive, is normally delivered while the person is awake, and does not ordinarily require general anesthesia. ECT involves a controlled therapeutic seizure under anesthesia and has a different evidence base, clinical role, treatment process, and risk profile.
ECT can be particularly important for severe depression, psychotic depression, catatonia, and some urgent psychiatric presentations. The fact that TMS is less intensive does not mean it is clinically preferable in every case.
The appropriate neuromodulation treatment depends on diagnosis, severity, urgency, previous response, medical history, risk, preference, and specialist psychiatric judgment.
Benefits and Limitations of TMS
For an appropriately selected client, potential advantages of TMS may include:
- noninvasive treatment without surgical implantation;
- treatment while awake;
- no routine requirement for general anesthesia;
- limited systemic medication exposure;
- ability to target selected cortical regions;
- compatibility with psychotherapy and other components of care;
- different treatment protocols for specific indications and devices.
Its limitations are equally important:
- not every person responds;
- treatment generally requires repeated sessions;
- the appropriate protocol depends on the indication and device;
- long-term durability varies;
- maintenance treatment may sometimes be considered;
- some applications remain off-label or investigational;
- access requires suitable equipment and appropriately trained professionals;
- TMS does not resolve the psychological, relational, behavioral, or environmental dimensions of illness by itself.
Safety and Possible Side Effects
TMS is generally considered well tolerated when delivered according to appropriate protocols by trained professionals, but it is not free of risk.
Possible adverse effects include:
- headache;
- scalp pain or discomfort;
- facial or scalp muscle twitching;
- temporary discomfort during stimulation;
- lightheadedness or fatigue;
- hearing-related risk if appropriate hearing protection is not used;
- changes in mood or activation in susceptible individuals;
- rare seizures.
Seizure is the most significant recognized acute risk associated with conventional repetitive TMS, although it is uncommon when established safety protocols are followed.
Screening becomes particularly important when there is a seizure history, neurological illness, medication that may alter seizure threshold, significant sleep deprivation, substance withdrawal, implanted electronic or metallic devices, or other relevant medical factors.
TMS should therefore be prescribed and supervised through an appropriate medical framework rather than approached as a wellness technology.
Who May Not Be Suitable for TMS?
Suitability depends on the device and protocol. Particular attention may be required for people with:
- certain metallic or electronic implants in or near the head;
- cochlear implants or other implanted hearing devices;
- deep brain stimulators or other implanted neurostimulation systems;
- a history of seizures or neurological conditions affecting seizure risk;
- acute substance withdrawal;
- significant medication changes;
- acute mania, psychosis, or psychiatric instability requiring a different treatment priority;
- medical conditions that require specialist review before treatment.
A detailed device-specific safety assessment is required because contraindications are not identical across all TMS systems.
How Many TMS Sessions Are Needed?
There is no universal number of TMS sessions.
Some established depression protocols involve treatment on multiple days each week over several weeks. Theta burst protocols can deliver stimulation much more quickly per session, while newer accelerated approaches may concentrate more treatments into a shorter period.
OCD, depression, smoking cessation, research protocols, and other applications may all use different treatment schedules.
THE BALANCE therefore does not promise a standard package or fixed number of sessions. The treatment proposal should identify the device, indication, protocol, anticipated course, review points, and criteria for continuation or discontinuation.
How Progress Is Evaluated
Progress should not be judged solely by completion of a TMS course or by technical treatment data.
The team should define what meaningful improvement would look like before treatment begins. Depending on the indication, this might include:
- changes in depressive symptoms;
- reduced obsessive-compulsive symptoms;
- reduced comorbid anxiety;
- changes in cravings or smoking behavior;
- improved sleep or daily functioning;
- greater capacity to participate in psychotherapy;
- improvement on appropriate validated clinical measures;
- reduced impairment in relationships, work, or everyday activity.
If the expected benefit does not emerge, or if adverse effects or a change in clinical priorities makes treatment inappropriate, the plan should be reconsidered.
TMS Within the THE BALANCE Model
At THE BALANCE, TMS is considered within Assessment and Treatment Planning and the Multidisciplinary Clinical Model.
When clinically appropriate, it may be coordinated alongside:
- psychiatric assessment and medication management;
- individual psychotherapy;
- trauma-focused treatment;
- addiction treatment;
- medical and neurological assessment;
- sleep treatment;
- nutrition and metabolic support;
- movement and physical rehabilitation;
- neurofeedback and other selected neurobiological techniques;
- family and relational work;
- continuing-care planning.
The presence of advanced technology does not make an intervention automatically valuable. The question is whether TMS addresses a clearly defined clinical priority for the individual and whether its contribution can be evaluated responsibly.
Fully Private TMS Treatment
THE BALANCE provides fully private residential treatment with each treatment program planned individually and exclusive accommodation in the private-villa arrangement.
For executives, founders, public figures, celebrities, internationally mobile families, and HNWI or UHNWI clients, this can allow psychiatric treatment and external specialist appointments to be coordinated with a high degree of discretion.
Where TMS is clinically indicated and available, treatment may be provided through an appropriately qualified independent specialist or suitable treatment facility and incorporated into the wider residential plan.
The proposal should specify the provider, treatment location, responsible clinician, device or protocol where relevant, expected schedule, privacy arrangements, transportation, consent process, and any separately charged services.
Website content should not be taken as confirmation that a particular TMS device or protocol is available at every THE BALANCE location.
Preparing for Continuing Care
TMS should not become disconnected from what happens after treatment.
If symptoms improve, the clinical team considers how those gains can be supported through psychotherapy, medication where appropriate, sleep, routines, relationships, behavior, physical health, work, stress management, and the environment to which the client returns.
Some people may require no further stimulation after an acute treatment course. Others may be considered for maintenance or repeat treatment according to response, indication, evidence, specialist advice, and access.
The goal is not dependence on a device. It is sustained improvement in the client’s functioning and quality of life.
